The first partner company is on the path to market, but the implications are clear: eXoZymes has created a scalable production engine for molecules that were previously too rare or expensive to make.

Scientists have discovered how to target a class of molecular switches called GTPases that are involved in a myriad of diseases from Parkinson's to cancer and have long been thought to be 'undruggable ...

Researchers from the University of Maryland School of Medicine (UMSOM) and the University of Alabama at Birmingham’s Heersink ...

RFdiffusion2, RFdiffusion3, and Riff-Diff each solve different structural problems in computational enzyme design ...

Researchers at Queen Mary University of London’s School of Biological and Behavioural Sciences, using the simple fission yeast as a model, have shown that a new target of rapamycin (TOR) inhibitor, ...

Viruses and their hosts—whether bacteria, animals, or humans—are locked in a constant evolutionary arms race. Cells evolve ...

(Nanowerk News) Industrial biocatalysis is mainly used for the production of pharmaceuticals and special chemicals. To advance this process, researchers are working on new process technologies. In ...

Cationic CDs, which possess a positively charged surface, have shown the ability to mimic natural enzyme applications. The positive charge on the surfaces of these nanomaterials significantly ...

Researchers from the Cluster of Excellence Balance of the Microverse at the University of Jena and the Leibniz-HKI, together ...

That’s the big idea behind Zymosense, “The Nanoassay Company,” a startup that’s spinning off technology developed in the lab ...